Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients--final analysis of a randomized, multicenter, phase III trial.
Haematologica. 2012 Oct;97(10):1562-9. doi: 10.3324/haematol.2011.060087. Epub 2012 Apr 17.
Haematologica. 2012.
PMID: 22511495
Free PMC article.
Clinical Trial.
High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study.
Petzer AL, Wolf D, Fong D, Lion T, Dyagil I, Masliak Z, Bogdanovic A, Griskevicius L, Lejniece S, Goranov S, Gercheva L, Stojanovic A, Peytchev D, Tzvetkov N, Griniute R, Oucheva R, Ulmer H, Kwakkelstein M, Rancati F, Gastl G.
Petzer AL, et al. Among authors: peytchev d.
Haematologica. 2010 Jun;95(6):908-13. doi: 10.3324/haematol.2009.013979. Epub 2010 Feb 9.
Haematologica. 2010.
PMID: 20145273
Free PMC article.
Clinical Trial.
Item in Clipboard
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A, Schoch R, Gattermann N, Sanz G, List A, Gore SD, Seymour JF, Bennett JM, Byrd J, Backstrom J, Zimmerman L, McKenzie D, Beach C, Silverman LR; International Vidaza High-Risk MDS Survival Study Group.
Fenaux P, et al.
Lancet Oncol. 2009 Mar;10(3):223-32. doi: 10.1016/S1470-2045(09)70003-8. Epub 2009 Feb 21.
Lancet Oncol. 2009.
PMID: 19230772
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase-I/II study to evaluate dose limiting toxicity, maximum tolerated dose, and tolerability of bendamustine HCl in pre-treated patients with B-chronic lymphocytic leukaemia (Binet stages B and C) requiring therapy.
Lissitchkov T, Arnaudov G, Peytchev D, Merkle Kh.
Lissitchkov T, et al. Among authors: peytchev d.
J Cancer Res Clin Oncol. 2006 Feb;132(2):99-104. doi: 10.1007/s00432-005-0050-z. Epub 2005 Nov 15.
J Cancer Res Clin Oncol. 2006.
PMID: 16292542
Clinical Trial.
Item in Clipboard
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.
Peyvandi F, Scully M, Kremer Hovinga JA, Cataland S, Knöbl P, Wu H, Artoni A, Westwood JP, Mansouri Taleghani M, Jilma B, Callewaert F, Ulrichts H, Duby C, Tersago D; TITAN Investigators.
Peyvandi F, et al.
N Engl J Med. 2016 Feb 11;374(6):511-22. doi: 10.1056/NEJMoa1505533.
N Engl J Med. 2016.
PMID: 26863353
Free article.
Clinical Trial.
Item in Clipboard
Granulocyte colony-stimulating factor (G-CSF) to harvest mobilized circulating haematopoietic stem cells for autotransplantation.
Brice P, Marolleau JP, Peytchev D, Giachetti S, Sitthy X, Djenander F, Benbunan M, Gisselbrecht C.
Brice P, et al. Among authors: peytchev d.
Leukemia. 1993 Nov;7(11):1928-9.
Leukemia. 1993.
PMID: 7694009
No abstract available.
Item in Clipboard
Cite
Cite